Respiratory Inhaler Device Sector: Growth Drivers and Challenges
Growth Drivers
-
Rising Air Pollution
- Growing Cases of Asthma
- Increasing Patients with Chronic Obstructive Pulmonary Disease
Challenges
-
Associated Side-Effects
Respiratory Inhaler Device Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.8% |
|
Base Year Market Size (2024) |
USD 38.85 billion |
|
Forecast Year Market Size (2037) |
USD 71.46 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of respiratory inhaler device is estimated at USD 40.44 billion.
Respiratory Inhaler Device Market size was valued at USD 38.85 billion in 2024 and is likely to cross USD 71.46 billion by 2037, expanding at more than 4.8% CAGR during the forecast period i.e., between 2025-2037.
North America industry is predicted to dominate majority revenue share by 2037, on the back of presence of a highly established healthcare infrastructure.
The major players in the market are Merck & Co., Inc., GlaxoSmithKline plc., Cipla Inc., and Koninklijke Philips N.V.
